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Supplemental vibrational force 
does not reduce pain experience 
during initial alignment with 
fixed orthodontic appliances: a 
multicenter randomized clinical 
trial
Neil R. Woodhouse1,2,*, Andrew T. DiBiase3,*, Spyridon N. Papageorgiou4,*, Nicola Johnson2, 
Carmel Slipper2, James Grant2, Maryam Alsaleh1 & Martyn T. Cobourne1
This prospective randomized trial investigated the effect of supplemental vibrational force on 
orthodontic pain during alignment with fixed-appliances. Eighty-one subjects < 20 years-old 
undergoing extraction-based fixed-appliance treatment were randomly allocated to supplementary 
(20-minutes/day) use of an intra-oral vibrational device (AcceleDent®) (n = 29); an identical non-
functional (sham) device (n = 25) or fixed-appliances only (n = 27). Each subject recorded pain 
intensity (using a 100-mm visual-analogue scale) and intake of oral analgesia in a questionnaire, 
following appliance-placement (T1) and first-adjustment (T2) for 1-week (immediately-after, 4, 
24, 72-hours and at 1-week). Mean maximum-pain for the total sample was 72.96 mm [SD 21.59; 
95%CI 68.19–77.74 mm] with no significant differences among groups (P = 0.282). Subjects taking 
analgesics reported slightly higher maximum-pain although this was not significant (P = 0.170). The 
effect of intervention was independent of analgesia (P = 0.883). At T1 and T2, a statistically and 
clinically significant increase in mean pain was seen at 4 and 24-hours, declining at 72-hours and 
becoming insignificant at 1-week. For mean alignment-rate, pain-intensity and use of analgesics, no 
significant differences existed between groups (P > 0.003). The only significant predictor for mean 
pain was time. Use of an AcceleDent vibrational device had no significant effect on orthodontic pain 
or analgesia consumption during initial alignment with fixed appliances.
Pain is a common consequence of orthodontic treatment with fixed appliances and this is often most sig-
nificant immediately following appliance placement1–3. Studies have shown that pain generally increases 
during the first 24 hours after the appliance has been fitted and then gradually reduces over the fol-
lowing week3–9. This cycle is often repeated as the teeth align and progressively stiffer archwires are 
placed, which can affect routine day-to-day activities, such as eating and sleeping; and often requires 
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the consumption of oral analgesia3,10. Indeed, there is evidence that orthodontic pain has the potential 
to negatively impact on some aspects of treatment, including compliance11, likelihood of completion12,13 
and overall outcome14.
Although conventional oral analgesics are effective in reducing orthodontic pain15, medications can 
be associated with side-effects and are contraindicated in some individuals. Given these potential nega-
tive factors, a number of studies have evaluated different interventions and their relationship to ortho-
dontic pain—particularly variation in appliance design. There has been some focus on pain associated 
with self-ligating versus conventional brackets during initial alignment, but little evidence exists of clini-
cally significant differences between these designs7–9,16,17, although the process of archwire insertion and 
removal can be more painful when using 3M SmartclipTM self-ligating brackets16,17. In terms of aligning 
archwires, martensitic-active copper nickel-titanium has been associated with greater pain intensity com-
pared with martensitic-stabilized18,19 and superelastic nickel-titanium has a significantly higher peak pain 
when compared to multistrand stainless steel20; however, the effects of nickel-titanium type appears to be 
marginal in other studies4,20 and overall, more evidence is needed21,22. Low-level laser therapy has also 
been described as a non-thermal biostimulatory pain-relieving adjunct to fixed appliance treatment23–29 
and whilst showing some promise, current evidence remains weak30,31.
There is evidence that vibrational stimulation can be effective in providing relief for various types 
of acute and chronic musculoskeletal pain32,33, sinus pain34 and indeed, pain of dental origin35. The 
pain-relieving effects of vibratory stimulation may be achieved by increasing vascularity and reducing 
areas of ischemia and through the activation of large-diameter sensory nerve fibers36. The concept of 
vibratory stimulation as a method of reducing pain following the adjustment of orthodontic appliances 
has also been described37. A number of devices are now commercially available that have been designed 
to provide cyclic vibratory force directly to the dentition as an adjunct to orthodontic treatment. Amongst 
these, AcceleDent® is a prescription-only removable, hands-free device that provides a vibrational fre-
quency of 30 Hz and force of 0.2 N to the dentition (Fig.  1). The patient gently bites onto a vibrating 
thermoplastic wafer for around twenty-minutes per day as a supplement to their orthodontic treatment. 
Although these appliances are marketed as a viable method of reducing pain during orthodontic treat-
ment, there is currently little evidence to support this38.
The aim of this randomized clinical trial was to investigate the effect of supplemental vibrational force 
with the AcceleDent appliance on pain during early tooth alignment with fixed orthodontic appliances. 
The null hypothesis is that supplemental vibrational force does not reduce pain associated with this phase 
of fixed appliance treatment.
Methods
Trial design and changes after trial commencement. This investigation reports a three-arm 
parallel-randomized controlled trial comparing the effects of supplemental vibrational force on ortho-
dontic pain during initial alignment with fixed appliances. Ethical approval was obtained from the 
United Kingdom National Research Ethics Service (South East London REC 3: 11/LO/0056) and written 
informed consent was received from all parents, guardians and children. All methods were performed 
in accordance with the approved guidelines and regulations. The trial was registered at the European 
Clinical Trials Database (EudraCT) (2014-004211-37) on 29 September 2014 and ClinicalTrials.gov 
(NCT02314975) on 25 November 2014. No changes to the methodology occurred following trial com-
mencement. We report and present data according to the CONSORT statement39.
Figure 1. (A) The AcceleDent device is a small, lightweight and portable vibrational appliance that consists 
of an activator unit (a) and a vibrating mouthpiece (m). (B) The patient gently bites down on the occlusal 
surfaces of the vibrating mouthpiece for 20 minutes per day.
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Participants, eligibility criteria, and settings. Participants were recruited from King’s College 
London Dental Institute (Guy’s Hospital) UK; Royal Alexander Children’s Hospital, Brighton, UK; and 
William Harvey Hospital, Ashford, UK between July 2011 and May 2014. Eligibility included the follow-
ing criteria: (1) under 20 years of age at treatment start; (2) no medical contraindications, including reg-
ular medication; (3) in the permanent dentition; (4) mandibular arch incisor irregularity; (5) extraction 
of mandibular first premolars as part of the orthodontic treatment plan.
Interventions. Participants were randomly assigned to one of three treatment groups: (1) Pre-adjusted 
edgewise fixed-appliance treatment with adjunctive daily use of a functional AcceleDent® (OrthoAccel® 
Technologies, Inc, Houston, Texas, USA) vibrational device (Accel-group); (2) Pre-adjusted edgewise 
fixed-appliance treatment with adjunctive use of a non-functional (sham) AcceleDent device (Accel-sham); 
and (3) Pre-adjusted edgewise fixed-appliance treatment alone (Fixed-only group). Subjects allocated to 
functional or sham devices were given direct verbal and written instruction on operation and usage, told 
to use the device for 20 minutes per day and shown that an electronic timer was part of the device, there-
fore allowing compliance monitoring. The sham device was identical to the active device in all respects, 
except that it did not vibrate. The bonding method and fixed appliance was standardized between groups 
(MBT prescription pre-coated 3M Victory series, 3M Unitek, Monrovia, USA). After bracket bonding, 
a pre-determined sequence of 0.014-inch and 0.018-inch nickel titanium archwires was used during 
the period of study. Archwires were inserted and ligated from first molar to first molar using conven-
tional elastomerics. Archwire progression occurred only if full bracket engagement was achievable, which 
required the relevant archwire to be fully tied into the base of the bracket slot adjacent to each tie wing 
using elastomeric ligation. All archwires were cut distal to the first molars and were not cinched. No bite 
planes, auxiliary arches, inter-maxillary elastics, headgears or temporary anchorage devices were used 
during the period of investigation. All subjects were treated by consultant orthodontists (ATD, NJ, CS, 
JG); or specialist registrars (NRW, MA) under their direct supervision.
Primary and secondary outcomes. Subjects were given a pain questionnaire to complete over the 
week following placement of the fixed appliance and insertion of the initial 0.014-inch nickel-titanium 
archwire (T1); and following insertion of a 0.018-inch nickel-titanium archwire (T2). The questionnaire 
recorded orthodontic pain immediately after, 4 hours, 24 hours, 3 days and 1 week following the appoint-
ment by means of a 100-mm visual analogue scale (VAS) using the terms “very comfortable” and “very 
uncomfortable” as peripheral weightings40. The VAS score is the distance from the left end of the line 
to the point of the subjects mark, measured to the nearest millimeter. Each VAS score was measured on 
two separate occasions by the same operator (NRW); with the mean taken as the representative value. 
In addition to the VAS score, subjects noted the consumption of oral analgesia during the period of 
observation. Each subject was free to take non-prescription oral analgesia, as required. The pain ques-
tionnaire was completed by the subject and returned at the following appointment. Tooth alignment was 
calculated using an irregularity-index, which measured the horizontal linear contact-point displacement 
of each mandibular incisor from the adjacent tooth and therefore represented the sum of the five indi-
vidual displacements41. Rate of initial alignment was calculated as the difference in irregularity-index of 
casts taken at T1 and T2 divided by the number of days between the two measurements and has been 
reported elsewhere42.
The primary outcome measure for this part of the trial was maximum pain experience during initial 
alignment with fixed orthodontic appliances, whilst secondary outcomes were (1) mean pain; (2) align-
ment rate; (3) use of oral analgesia; and (4) number and type of oral analgesia taken during this period 
of treatment. There were no changes to outcomes following trial commencement.
To examine measurement reliability, 30 sets of VAS scores were selected and re-measured blind two 
weeks following the original measurement by one assessor (NRW) and the intra-class correlation coeffi-
cient was calculated. Repeatability of the measurements was found to be almost perfect (coefficient and 
its 95% CI included only values above 0.99).
Sample size calculation. Sample size calculation for this trial was based upon the outcome of initial 
rate of orthodontic tooth alignment, which gave a required sample of 23 per group and has been described 
previously42. A previous investigation of orthodontic pain using fixed appliances in two groups of UK 
subjects during initial alignment adopted a difference of 20 mm on the VAS scale as being clinically sig-
nificant7. Post hoc power analysis, using a three-group one-way ANOVA to identify the above-mentioned 
difference, with a root mean square error of 21.51 mm (originating from results of the present trial) and 
a significance of 0.05, indicated that this trial would yield a power between 82.9% and 89.6%.
Interim analyses and stopping guidelines. Not applicable.
Randomization. The randomization sequence was generated by one investigator (MTC) using 
GraphPad online software (http://www.graphpad.com/quickcalcs/index.cfm) with unrestricted equal 
participant allocation (1:1:1) undertaken centrally at King’s College London, independently from the 
clinical operators, following recruitment (allocation concealment)43.
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Blinding. Treating clinicians and subjects could not be blinded to the use of AcceleDent; however, 
subjects were blinded to the allocation of functional or sham appliances, as both were identical in appear-
ance (with the exception that the sham appliance did not vibrate). The pain questionnaires and extracted 
data were coded appropriately, so that both outcome assessor (NRW) and statistician (SNP) were blinded 
to subject allocation. The coding of the data was broken after the end of the analysis and no breach of 
blinding was identified.
Statistical analysis. We report and present data according to the relevant CONSORT statement39. 
Demographic and clinical characteristics were investigated with conventional descriptive statistics. 
Differences between groups for single time-points were initially identified among groups with inde-
pendent t-tests, Analyses of Variance (ANOVAs) and chi-square tests after checking for homoscedacity 
and normality of residuals. The effect of the intervention on primary and secondary outcomes was inves-
tigated using multivariable linear or logistic regression modeling with robust standard errors, adjusted 
for any possible confounders, including demographics (sex, age) and clinical characteristics (mandibular 
incisor irregularity at T1). Analyses were also adjusted for the use of oral analgesia and alignment rate 
between T1-T2, whenever possible. In the analysis of mean pain across time-points, the model accounted 
for within-patient or time-point correlations. Residuals analysis was conducted to confirm no violation 
of the linear regression assumptions. All analyses were carried out using Stata 12.0 (Statacorp, College 
Station, TX, USA). A 2-tailed P-value of 0.05 was considered statistically significant with a 95% confi-
dence interval (CI) for all tests. Crude Bonferroni adjustments of the significance level were conducted 
for the analyses of the secondary outcomes, which were regarded as exploratory44.
Results
Participant flow. This three-arm parallel-randomized controlled trial included 81 participants (40 
males and 41 females) with a mean age of 14.1 [standard deviation (SD), 1.7] years. Overall, 29 subjects 
were allocated to the Accel-group, 25 to the Accel-sham and 27 to the Fixed-only group. Progress of 
subjects through the trial is shown in the CONSORT diagram in Fig.  2. A total of 80/81 (99%) and 
77/81 (95%) of subjects returned completed questionnaires at T1 and T2, respectively. Missingness was 
not substantial and therefore classified as missing at random, as it was not dependent on any covariate: 
Figure 2. CONSORT diagram showing the flow of subjects through the trial. Note that data were lost at 
T1 for 1 subject (#11 allocated to fixed-only, but this person remained in the trial and T2 data was obtained). 
Note that subjects #22 allocated to Accel and #26 allocated to Accel-sham also discontinued the intervention 
but after the collection of T2 pain data. This has been previously reported as final alignment data was not 
obtained for these individuals42.
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of those that were recruited, only 1 was lost at T1 (1 Fixed-only group) and 4 at T2 (1 Accel-group; 1 
Sham-group and 2 Fixed-only group).
Baseline data. Table  1 shows baseline demographics and clinical characteristics of the randomized 
groups. All three randomized groups were comparable for age, sex, recruitment site and irregularity-index. 
For the total sample, mean irregularity-index at T0 was 8.5 mm [SD 3.8; 95% CI 7.6 to 9.3] whilst at T2 
it was 2.7 mm [SD 2.8; 95% CI 2.2 to 3.4].
Primary outcome and subgroup analysis. Mean maximum pain intensity across all time-points 
for the total sample was 72.96 mm [SD 21.59; 95% CI 68.19 to 77.74 mm] with no significant differences 
among groups (Table 2; P = 0.282). Multivariable regression analysis indicated that even after account-
ing for all confounders, there were no significant differences between experimental groups (Table  3). 
However, subject age was marginally significant, with younger subjects reporting higher maximum pain 
(P = 0.047).
Subgroup analysis according to the use of oral analgesia indicated that subjects taking analgesics 
reported slightly higher maximum pain intensity compared to those who did not (75.24 mm compared 
to 68.15 mm, respectively), although this was not statistically significant (Table 2; P = 0.170). The effect 
of intervention among groups was independent of whether oral analgesia was taken or not (P = 0.883).
Secondary outcomes. Mean alignment rate, mean pain intensity at each time-point and reported 
use of oral analgesics amongst the three groups is shown in Supplementary Table S1. The mean overall 
alignment rate between T1-T2 was 0.10 mm/day (SD 0.05; 95% CI 0.09 to 0.12 mm/day), whilst mean 
pain intensity varied considerably at the individual time-points after T1 and T2. Overall, a total of 55 
(69%) patients at T1 and 26 (34%) patients at T2 reported taking any kind of oral analgesia. For all 
secondary outcomes studied, no statistically significant difference could be found among the three exper-
imental groups (P > 0.003 due to Bonferroni correction).
Multivariable linear regression for mean pain intensity at each time-point (Supplementary Table S2) 
indicated that the only significant predictor of pain intensity was time, although the amount of irregular-
ity at T2 was marginally significant (P = 0.048). Both after T1 and T2, a statistically and clinically signifi-
cant increase in pain was seen at 4 and 24 hours following archwire placement, which declined at 72 hours 
and became insignificant at 1 week (Fig.  3). When taking into account possible confounders through 
Characteristic Accel-group Accel-sham Fixed-only
Age (years)—mean [SD] 13.9 [1.6] 13.8 (1.7) 14.4 [1.9]
Male/female 15/14 13/12 12/15
Trial site, n
 Guy’s 5 5 8
 Brighton 11 11 11
 Ashford 13 9 8
Irregularity (mm)—mean [95% CI]
 Baseline (T1) 8.3 [6.7–9.9] 8.1 [6.8–9.5] 8.9 [7.4–10.5]
 Initial alignment (T2) 2.8 [1.8–3.8] 2.2 [1.4–3.0] 3.3 [1.9–4.7]








valuen Mean (SD) n Mean (SD) n Mean (SD) n Mean (SD)
Overall 81 72.96 (21.59) 29 76.28 (18.86) 25 67.32 (23.81) 27 74.63 (21.95) 0.282*
Oral analgesia: NO 26 68.15 (24.15) 0.170† 8 71.63 (27.42) 10 61.80 (18.33) 8 72.63 (28.38) 0.883‡
Oral analgesia: YES 55 75.24 (20.10) 21 78.05 (14.93) 15 71.00 (26.82) 19 75.47 (19.49)
Table 2.  Reported maximum pain from each patient across all time-points and subgroup analysis 
according to use of oral analgesia. SD, standard deviation. *P value for differences among experimental 
groups from one-way ANOVA. †P value for differences between subgroups NO/YES oral analgesia from 
independent t-test. ‡P value for interaction between use of pain medication and the three experimental 
groups from two-way ANOVA.
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multivariable logistic or linear regression, the use of a functional AcceleDent device or AcceleDent-sham 
device had no significant effect on the reported use of oral analgesia (Supplementary Table S3) or the 
number of oral analgesics taken after T1 or T2 (Supplementary Table S4). A marginally significant effect 
of subject age on number of paracetamol (acetaminophen) taken was seen at T1 (P = 0.043).
No harms were recorded for any subjects within the trial, except pain after insertion of the archwire 
at T1 and T2.
Discussion
This randomized controlled trial found no evidence of a significant difference in orthodontic pain during 
initial tooth alignment between subjects treated with fixed appliances supplemented with the daily appli-
cation of vibrational force and those treated with fixed appliances alone. Tooth movement and alignment 
was able to proceed normally in subjects using functional and non-functional vibratory devices with no 
significant differences between randomized groups. The use of vibrational force had no significant influ-
ence on the reported use of analgesics. The only significant predictor of pain intensity was time, with a 
clinically significant increase in pain being seen at 4 and 24 hours following the placement of alignment 
archwires at both time-points, which declined at 72 hours and became insignificant at 1 week. Marginally 
Overall (n = 80)
P valueFactor Coefficient (95% CI)
Gender − 3.69 (− 13.05,5.68) 0.441
Age − 2.40 (− 4.76,− 0.03) 0.047
Irregularity − 0.02 (− 1.58,1.54) 0.977
Oral analgesia use 4.14 (− 5.74,14.02) 0.412
Alignment rate 91.53 (− 4.37,187.42) 0.061
Experimental groups Accel-group 0.14 (− 10.06,10.35) 0.978
Accel-sham − 9.42 (− 21.34,2.50) 0.121
Fixed-only Reference
Table 3.  Multivariable regression for the primary outcome (maximum pain for each patient across 
all time-points). Interaction terms: oral analgesia with group: P = 0.715; alignment with group: P = 0.189; 
irregularity with group: P = 0.123. CI, confidence interval.
Figure 3. Mean pain intensity at each time-point after T1 and T2 according to intervention (predictive 
margins of time with 95% CIs). 
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significant effects were identified between maximum reported pain and subject age, mean pain and 
irregularity at T2, and between subject age and the number of paracetamol taken at T2. However, these 
were all secondary factors that only just reached statistical significance and were therefore unlikely to be 
of clinical significance.
This investigation has a number of strengths, which include the multicenter design and strict random-
ization with concealed allocation, a low drop-out rate amongst recruited subjects and a high percentage 
return of pain questionnaires. All three randomized groups were comparable for age, sex, recruitment 
site and irregularity-index. In addition, orthodontic pain experience was measured longitudinally at two 
important time-points during the alignment phase of routine fixed appliance orthodontic treatment. 
Although the a priori sample size calculation was not based upon the outcome of orthodontic pain42, 
post hoc analysis indicated a power of >80% to detect a clinically meaningful difference in pain. Due to 
the broad inclusion criteria used and the balanced characteristics of the three groups, the results of this 
trial are applicable to most subjects under 20 years of age undergoing routine orthodontic treatment with 
fixed appliances for the correction of mandibular crowding. This is the first randomized clinical trial 
to investigate orthodontic pain in association with use of the market-leading supplemental vibrational 
device and provides a high-level of evidence to inform clinical practice.
A potential limitation of this study is the absence of definitive compliance data relating to use of the 
active and sham devices. Both were provided directly by the manufacturer and were fitted with electronic 
timers designed to measure usage. Unfortunately, these timers proved to be unreliable and obtaining a 
definitive dataset to inform the analysis was not possible. Subjects were carefully monitored for compli-
ance during the trial, being asked to bring their appliance with them for use prior to each appointment, 
demonstrate continued familiarity with operation and allow inspection for evidence of use. This was a 
pragmatic study designed to investigate supplementary vibrational force during routine everyday ortho-
dontic practice as part of the overall management of subjects with malocclusion. The first data-set was 
obtained during the week immediately following appliance placement and it would be expected that for a 
simple removable device, compliance levels would be high. A lack of true blinding may also be regarded 
as a limitation, but the blinding of operators and subjects was not practical. Subjects were blinded to the 
allocation of functional or sham devices, but the lack of vibration associated with the sham appliance 
meant that for some, the specific allocation became apparent. However, the randomization of subjects to 
treatment with a sham device was justified, providing a placebo within the trial, which did not adversely 
affect drop out rates during the period of investigation.
The use of supplemental vibrational force has been advocated as a simple non-invasive method of 
improving the efficiency of orthodontic treatment with fixed appliances. In particular, as a method of 
increasing rates of tooth movement during alignment, leveling and translation45–47; however, this evi-
dence is conflicting38,42. To date, the pain-relieving properties of vibrational therapy during tooth align-
ment with fixed appliances has only been evaluated in relation to the Tooth Massuese device, and has 
been found to make no significant difference on the basis of VAS scores38. Here, we have focused specif-
ically on pain during the first two phases of alignment, in the first week following appliance placement 
and following the first adjustment, finding no significant differences between groups. There were no 
differences between groups in relation to maximum pain at any time-point or the patterns of mean pain 
during the week following T1 and T2. In general, mean pain peaked within the first few hours after the 
appointment and then declined to baseline levels at 7 days. These findings are consistent with previous 
studies of orthodontic pain during the alignment phase of treatment4,7–9,17.
There is evidence that non-prescription oral analgesia can be effective in the management of pain 
following the activation of fixed orthodontic appliances, particularly nonsteroidal anti-inflammatory 
drugs at 6 and 24 hours following initial archwire placement15. In this investigation, around two-thirds 
of subjects at T1 and one third at T2 reported the consumption of oral analgesia. However, the use of a 
functional or sham AcceleDent device had no significant effect on this; or indeed, the number of anal-
gesics taken at either time-point. Therefore, vibrational force does not reduce the levels of pain reported 
or influence the consumption of oral analgesia.
This study has indicated that supplemental vibrational force provides no added value during initial 
tooth alignment with fixed appliances in terms of reducing the pain associated with this process. Given 
that this device is unlikely to be reimbursed in most countries, orthodontists should carefully consider 
their advice to orthodontic patients considering the use of AcceleDent as a method of pain relief. Current 
evidence would suggest that in appropriate patients, conventional non-prescription analgesia should be 
recommended if pain relief is required, with the caveat that pain is likely to reduce after the first 24 hours 
following archwire ligation and that in general, pain will be insignificant after a week.
This prospective randomized clinical trial has found no evidence that supplemental vibrational force 
with an AcceleDent removable device can (1) reduce pain; or (2) the consumption of analgesics during 
the alignment phase of fixed appliance orthodontic treatment.
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